AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
Angiotensin type 1 receptor antagonism reverses unormal coronary vasomotion in atherosclerosis
Authors: Prasad, A Halcox, JPJ Waclawiw, MA Quyyumi, AA
Citation: A. Prasad et al., Angiotensin type 1 receptor antagonism reverses unormal coronary vasomotion in atherosclerosis, J AM COL C, 38(4), 2001, pp. 1089-1095
Racial divergence in adiposity during adolescence: The NHLBI growth and health study
Authors: Kimm, SYS Barton, BA Obarzanek, E McMahon, RP Sabry, ZI Waclawiw, MA Schreiber, GB Morrison, JA Similo, S Daniels, SR
Citation: Sys. Kimm et al., Racial divergence in adiposity during adolescence: The NHLBI growth and health study, PEDIATRICS, 107(3), 2001, pp. NIL_30-NIL_36
Effects of inhaled oxide on regional blood flow are consistent with intravascular nitric oxide delivery
Authors: Cannon, RO Schechter, AN Panza, JA Ognibene, FP Pease-Fye, ME Waclawiw, MA Shelhamer, JH Gladwin, MT
Citation: Ro. Cannon et al., Effects of inhaled oxide on regional blood flow are consistent with intravascular nitric oxide delivery, J CLIN INV, 108(2), 2001, pp. 279-287
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
Authors: McDermott, DH Halcox, JPJ Schenke, WH Waclawiw, MA Merrell, MN Epstein, N Quyyumi, AA Murphy, PM
Citation: Dh. Mcdermott et al., Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis, CIRCUL RES, 89(5), 2001, pp. 401-407
Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management
Authors: Zanger, D Yang, BK Ardans, J Waclawiw, MA Csako, G Wahl, LM Cannon, RO
Citation: D. Zanger et al., Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management, J AM COL C, 36(6), 2000, pp. 1797-1802
The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity
Authors: Prasad, A Narayanan, S Waclawiw, MA Epstein, N Quyyumi, AA
Citation: A. Prasad et al., The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity, J AM COL C, 36(5), 2000, pp. 1579-1586
Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women
Authors: Blum, A Hathaway, L Mincemoyer, R Schenke, WH Kirby, M Csako, G Waclawiw, MA Panza, JA Cannon, RO
Citation: A. Blum et al., Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women, J AM COL C, 35(2), 2000, pp. 271-276
Practical guidelines for multiplicity adjustment in clinical trials
Authors: Proschan, MA Waclawiw, MA
Citation: Ma. Proschan et Ma. Waclawiw, Practical guidelines for multiplicity adjustment in clinical trials, CONTR CL TR, 21(6), 2000, pp. 527-539
Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans
Authors: Gladwin, MT Shelhamer, JH Schechter, AN Pease-Fye, ME Waclawiw, MA Panza, JA Ognibene, FP Cannon, RO
Citation: Mt. Gladwin et al., Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans, P NAS US, 97(21), 2000, pp. 11482-11487
Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease - Sex-based differences in inflammation and type of immune response
Authors: Zhu, JH Shearer, GM Norman, JE Pinto, LA Marincola, FM Prasad, A Waclawiw, MA Csako, G Quyyumi, AA Epstein, SE
Citation: Jh. Zhu et al., Host response to cytomegalovirus infection as a determinant of susceptibility to coronary artery disease - Sex-based differences in inflammation and type of immune response, CIRCULATION, 102(20), 2000, pp. 2491-2496
Oral L-arginine in patients with coronary artery disease on medical management
Authors: Blum, A Hathaway, L Mincemoyer, R Schenke, WH Kirby, M Csako, G Waclawiw, MA Panza, JA Cannon, RO
Citation: A. Blum et al., Oral L-arginine in patients with coronary artery disease on medical management, CIRCULATION, 101(18), 2000, pp. 2160-2164
Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women
Authors: Blum, A Schenke, WH Hathaway, L Mincemoyer, R Csako, G Waclawiw, MA Cannon, RO
Citation: A. Blum et al., Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women, AM J CARD, 86(8), 2000, pp. 892
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
Authors: Zhu, JH Quyyumi, AA Norman, JE Csako, G Waclawiw, MA Shearer, GM Epstein, SE
Citation: Jh. Zhu et al., Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels, AM J CARD, 85(2), 2000, pp. 140-146
Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator Raloxifene in hypercholesterolemic men
Authors: Blum, A Hathaway, L Mincemoyer, R Schenke, WH Csako, G Waclawiw, MA Panza, JA Connon, RO
Citation: A. Blum et al., Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator Raloxifene in hypercholesterolemic men, AM J CARD, 85(12), 2000, pp. 1491
Compliance to multiple interventions in a high risk population
Authors: Pettinger, MB Waclawiw, MA Davis, KB Thomason, T Garg, R Griffin, B Egan, DA
Citation: Mb. Pettinger et al., Compliance to multiple interventions in a high risk population, ANN EPIDEMI, 9(7), 1999, pp. 408-418
Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha 1-antitrypsin deficiency
Authors: Novoradovsky, A Brantly, ML Waclawiw, MA Chaudhary, PP Ihara, H Qi, L Eissa, NT Barnes, PM Gabriele, KM Ehrmantraut, ME Rogliani, P Moss, J
Citation: A. Novoradovsky et al., Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha 1-antitrypsin deficiency, AM J RESP C, 20(3), 1999, pp. 441-447
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A post hoc analysis of the studies of left ventricular dysfunction
Authors: Exner, DV Dries, DL Waclawiw, MA Shelton, B Domanski, MJ
Citation: Dv. Exner et al., Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A post hoc analysis of the studies of left ventricular dysfunction, J AM COL C, 33(4), 1999, pp. 916-923
Psychometric properties of the self-perception profile for children in a biracial cohort of adolescent girls: The NHLBI growth and health study
Authors: Schumann, BC Striegel-Moore, RH McMahon, RP Waclawiw, MA Morrison, JA Schreiber, GB
Citation: Bc. Schumann et al., Psychometric properties of the self-perception profile for children in a biracial cohort of adolescent girls: The NHLBI growth and health study, J PERS ASSE, 73(2), 1999, pp. 260-275
Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study
Authors: Morrison, JA Sprecher, DL Barton, BA Waclawiw, MA Daniels, SR
Citation: Ja. Morrison et al., Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study, J PEDIAT, 135(4), 1999, pp. 458-464
Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women
Authors: Koh, KK Cardillo, C Bui, MN Hathaway, L Csako, G Waclawiw, MA Panza, JA Cannon, RO
Citation: Kk. Koh et al., Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women, CIRCULATION, 99(3), 1999, pp. 354-360
Vascular effects of estrogen and vitamin E therapies in postmenopausal women
Authors: Koh, KK Blum, A Hathaway, L Mincemoyer, R Csako, G Waclawiw, MA Panza, JA Cannon, RO
Citation: Kk. Koh et al., Vascular effects of estrogen and vitamin E therapies in postmenopausal women, CIRCULATION, 100(18), 1999, pp. 1851-1857
White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the studies of left ventricular dysfunction [SOLVD])
Authors: Cooper, HA Exner, DV Waclawiw, MA Domanski, MJ
Citation: Ha. Cooper et al., White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the studies of left ventricular dysfunction [SOLVD]), AM J CARD, 84(3), 1999, pp. 252-257
Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of leftventricular dysfunction)
Authors: Rashid, H Exner, DV Mirsky, I Cooper, HA Waclawiw, MA Domanski, MJ
Citation: H. Rashid et al., Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of leftventricular dysfunction), AM J CARD, 84(3), 1999, pp. 299-303
Rationale and design of the arterial disease multiple intervention trial (ADMIT) pilot study
Authors: Egan, DA Garg, R Wilt, TJ Pettinger, MB Davis, KB Crouse, J Herd, JA Hunninghake, DB Sheps, DS Kostis, JB Probstfield, J Waclawiw, MA Applegate, W Elam, MB
Citation: Da. Egan et al., Rationale and design of the arterial disease multiple intervention trial (ADMIT) pilot study, AM J CARD, 83(4), 1999, pp. 569-575
Mechanism by which Quinarpril improves vascular function in coronary artery disease
Authors: Koh, KK Bui, MN Hathaway, L Csako, G Waclawiw, MA Panza, JA Cannon, RO
Citation: Kk. Koh et al., Mechanism by which Quinarpril improves vascular function in coronary artery disease, AM J CARD, 83(3), 1999, pp. 327-331
Risultati: 1-25 | 26-26